Full Access with Signal8 Pro, $49/mo billed annually.
Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida.
Sector: Medicinal Chemicals & Botanical Products
Industry: Medical - Pharmaceuticals
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 850.17M shares outstanding
Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States.
It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety.
The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida.
Benjamin Kaplan
Chairman, Chief Executive and Financial Officer & President
Employees
1
Country
US
Sector
Healthcare
Website
aibotics.ai
Loading congressional disclosures…
based on 850.17M shares outstanding
30d Avg
33.93M
60d Avg
22.52M
90d Avg
17.04M